Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 4Breast Neoplasms 3Pain 2Lung Neoplasms 2Uterine Cervical Dysplasia 1Thyroid Neoplasms 1Supratentorial Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Postoperative Hemorrhage 1Nerve Block 1Musculoskeletal Diseases 1Mouth Neoplasms 1Malignant Neoplasms of Male Genital Organs 1Hypotension 1Head and Neck Neoplasms 1Goiter 1Chronic Pain 1Carcinoma, Renal Cell 1Bowen's Disease 1Agnosia 1Acute Upper Gastrointestinal Bleeding 1Acute Pain 1

Interventions

parathyroid hormone-related peptide (1-36) 2Cholecalciferol 2guizhi-shaoyao-zhimu decoction 1Xylitol 1Sodium Chloride 1Parathyroid Hormone-Related Protein 1Parathyroid Hormone 1Epinephrine 1Clonidine 1Bone Marrow Transplantation 1Adrenal Cortex Hormones 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Musculoskeletal Diseases × Epinephrine × Clear all
NCT05355597 2025-04-09

"The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors"

Atlantic Health System

Phase 2 Terminated
116 enrolled

Musculoskeletal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡